そうだったのか！　実臨床で必要な輸液の考え方

出版社： 羊土社
著者：
発行日： 2023-10-25
分野： 臨床医学：一般  >  栄養/食事/輸血
ISBN： 9784758124058
電子書籍版： 2023-10-25 （第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

商品紹介

目の前の患者に必要な輸液が今度こそわかる！外来・病棟で輸液を使いこなすために必要な情報を，症例を交えて解説．輸液の基本はもちろん，個々の患者に合わせた輸液の処方から治療までがこの1冊で絶対にできる！

目次

  • 第１章　総論
    　1．輸液を理解するために必要な知識の整理
    　2．輸液の適応を考えるうえでの体液量の評価方法を学ぶ
    　3．輸液の基本
    　4．輸液製剤の種類と体液量欠乏・過剰への介入

    第２章　電解質異常
    　1．高Na血症に対する輸液
    　2．低Na血症に対する輸液
    　3．高K血症に対する輸液
    　4．低K血症に対する輸液
    　5．高Ca血症に対する輸液

    第３章　コモンディジーズ
    　1．循環器：心不全患者の輸液
    　2．下痢・嘔吐を呈した症例の輸液マネジメント
    　3．消化管穿孔周術期の輸液
    　4．腎移植患者の周術期の輸液
    　5．終末期がん患者（緩和ケア）の輸液
    　6．造影剤腎症

    付録：主な輸液製剤

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 総論

P.15 掲載の参考文献
1) 長浜正彦:体液生理学の基礎知識-水・電解質の分布とバランス-, Medical Practice, 37:2-9, 2020
Medical*Online
2) [Clinical Physiology of Acid-Base and Electrolyte Disorders](Burton DR&Theodore P, eds), pp241-284, McGraw Hill/Medical, 2001
 
3) [Fluid, Electrolyte and Acid-Base Physiology:A Problem-Based Approach 4th Edition](Mitchell LH, et al, eds), pp245-313, Saunders, 2010
 
4) 「輸液スーパー指南塾」(長浜正彦/編), pp197-206, 羊土社, 2013
 
P.28 掲載の参考文献
1) McGee S, et al:The rational clinical examination. Is this patient hypovolemic? JAMA, 281:1022-1029, 1999(PMID:10086438)
 
2) Frank Peacock W & Soto KM:Current technique of fluid status assessment. Congest Heart Fail, 16 Suppl 1:S45-S51, 2010(PMID:20653711)
 
3) Beigel R, et al:Noninvasive evaluation of right atrial pressure. J Am Soc Echocardiogr, 26:1033-1042, 2013(PMID:23860098)
 
4) 「マクギーのフィジカル診断学 原著第4版」(Steven McGee/著, 徳田安春/総監訳, 志水太郎, 他/監訳), p294(Figure 34-1), 診断と治療社, 2019
 
5) 日本臨床検査標準協議会:「日本における主要な臨床検査項目の共用基準範囲」(日本臨床検査標準協議会, 基準範囲共用化委員会/編), 2019 https://www.jccls.org/wp-content/uploads/2020/11/public_20190222.pdf
 
6) 韓 蔚, 市川大介:第1章-4. 輸液の必要な患者とその診断法-輸液に関する臨床検査とその読み方-. Medical Practice, 37(臨時増刊号):22-26, 2020
 
7) Kalantari K, et al:Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int, 83:1017-1028, 2013(PMID:23302716)
 
8) Ely EW & Haponik EF:Using the chest radiograph to determine intravascular volume status:the role of vascular pedicle width. Chest, 121:942-950, 2002(PMID:11888980)
 
9) Rivers E, et al:Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 345:1368-1377, 2001(PMID:11794169)
 
10) Teboul JL, et al:SvO2 to monitor resuscitation of septic patients:let's just understand the basic physiology. Crit Care, 15:1005, 2011(PMID:22078239)
 
11) Monnet X, et al:Prediction of fluid responsiveness:an update. Ann Intensive Care, 6:111, 2016(PMID:27858374)
 
12) Kimura BJ, et al:The effect of breathing manner on inferior vena caval diameter. Eur J Echocardiogr, 12:120-123, 2011(PMID:20980326)
 
13) Stawicki SP, et al:Intensivist use of hand-carried ultrasonography to measure IVC collapsibility in estimating intravascular volume status:correlations with CVP. J Am Coll Surg, 209:55-61, 2009(PMID:19651063)
 
14) 亀田 徹, 他:超音波検査を用いた下大静脈の観察による循環動態の評価. 日救急医会誌, 24:903-915, 2013
 
15) Marik PE, et al:Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients:a systematic review of the literature. Crit Care Med, 37:2642-2647, 2009(PMID:19602972)
 
P.42 掲載の参考文献
1) Malbrain MLNG, et al:Principles of fluid management and stewardship in septic shock:it is time to consider the four D's and the four phases of fluid therapy. Ann Intensive Care, 8:66, 2018(PMID:29789983)
 
2) Padhi S, et al:Intravenous fluid therapy in adults in hospital:summary of NICE guidance. BMJ, 347:f7073, 2013(PMID:24326887) https://www.nice.org.uk/guidance/cg174
 
3) Rivers E, et al:Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 345:1368-1377, 2001(PMID:11794169)
 
4) Ferrer R, et al:Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA, 299:2294-2303, 2008(PMID:18492971)
 
5) Yealy DM, et al:A randomized trial of protocol-based care for early septic shock. N Engl J Med, 370:1683-1693, 2014(PMID:24635773)
 
6) Peake SL, et al:Goal-directed resuscitation for patients with early septic shock. N Engl J Med, 371:1496-1506, 2014(PMID:25272316)
 
7) Mouncey PR, et al:Trial of early, goal-directed resuscitation for septic shock. N Engl J Med, 372:1301-1311, 2015(PMID:25776532)
 
8) 「日本版敗血症診療ガイドライン2020」(日本版敗血症診療ガイドライン2020特別委員会/編), 日本集中治療医学会, 2021 https://www.jsicm.org/pdf/jjsicm28Suppl.pdf
 
9) Robinson AG:Disorders of antidiuretic hormone secretion. Clin Endocrinol Metab, 14:55-88, 1985(PMID:3893810)
 
10) McGee S, et al:The rational clinical examination. Is this patient hypovolemic? JAMA, 281:1022-1029, 1999(PMID:10086438)
 
11) Hoorn EJ, et al:Development of severe hyponatraemia in hospitalized patients:treatment-related risk factors and inadequate management. Nephrol Dial Transplant, 21:70-76, 2006(PMID:16141458)
 
12) Jacob M, et al:Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol, 108:347, 2013(PMID:23563917)
 
13) Egal M, et al:Targeting Oliguria Reversal in Goal-Directed Hemodynamic Management Does Not Reduce Renal Dysfunction in Perioperative and Critically Ill Patients:A Systematic Review and Meta-Analysis. Anesth Analg, 122:173-185, 2016(PMID:26505575)
 
14) Ding X, et al:Intravenous Fluids and Acute Kidney Injury. Blood Purif, 43:163-172, 2017(PMID:28114128)
 
15) Malbrain ML, et al:Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients:a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther, 46:361-380, 2014(PMID:25432556)
PubMed
16) Finfer S, et al:A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med, 350:2247-2256, 2004(PMID:15163774)
 
17) Annane D, et al:Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock:the CRISTAL randomized trial. JAMA, 310:1809-1817, 2013(PMID:24108515)
 
P.66 掲載の参考文献
1) 江木盛時, 他:日本版 敗血症診療ガイドライン 2020. 日集中医誌, 28(Suppl):S1-S411, 2021
 
2) 有吉 亨:VI 基本計測項目 3 ドプラ法. 「レジデントのための心エコー教室」(藤田雅史/編), p73, 日本医事新報社, 2021
 
3) Hoorn EJ, et al:50 Diuretics. 「Brenner and Rector's The Kidney 11th ed」(Alan SL Yu, et al, eds), pp1708-1740, Elsevier, 2019
 
4) Ute IS, et al:36 Inherited Disorders of Renal Salt Homeostasis Insights from Molecular Genetics Studies. 「Seldin and Giebisch's The Kidney 5th ed」(Alpern RJ, et al/eds), pp1213-1240, Academic Press, 2013
 
5) Ellison DH & Felker GM:Diuretic Treatment in Heart Failure. N Engl J Med, 377:1964-1975, 2017(PMID:29141174)
 
6) Packer M, et al:Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med, 383:1413-1424, 2020(PMID:32865377)
 
7) McMurray JJV, et al:Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med, 381:1995-2008, 2019(PMID:31535829)
 
8) Cherney DZ, et al:Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation, 129:587-597, 2014(PMID:24334175)
 
9) Heerspink HJL, et al:Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med, 383:1436-1446, 2020(PMID:32970396)
 
10) John S & Eckardt KU:Renal replacement strategies in the ICU. Chest, 132:1379-1388, 2007(PMID:17934125)
 
11) Flythe JE, et al:Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int, 79:250-257, 2011(PMID:20927040)
 

第2章 電解質異常

P.78 掲載の参考文献
1) 「より理解を深める!体液電解質異常と輸液 改訂3版」(深川雅史/監, 柴垣有吾/著), 中外医学社, 2007
 
2) Carson JM & Linas SL:Chapter 8. Hypernatremia. [National Kidney Foundation Primer on Kidney Diseases 8th ed](Gilbert SF, et al/eds), Elsevier, 2022
 
3) 「腎臓病診療に自信がつく本 第2版」(小松康宏/著), カイ書林, 2016
 
P.96 掲載の参考文献
1) Robertson GL & Athar S:The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab, 42:613-620, 1976(PMID:1262438)
 
2) 日本内分泌学会:バソプレシン分泌過剰症(SIADH)の診断と治療の手引き(平成30年度改訂)
 
3) Spasovski G, et al:Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol, 170:G1-47, 2014(PMID:24569125)
 
P.109 掲載の参考文献
1) [Comprehensive Clinical Nephrology 2nd ed](Johnson RJ, et al, eds), Mosby, 2003
 
2) 「輸液グリーンノート」(志水英明/編著), 中外医学社, 2021
 
3) Clase CM, et al:Potassium homeostasis and management of dyskalemia in kidney diseases:conclusions from a Kidney Disease:Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 97:42-61, 2020(PMID:31706619)
 
4) 「研修医のための輸液・水電解質・酸塩基平衡」(藤田芳郎, 他/編), 中外医学社, 2015
 
5) 長浜正彦:血清カリウム濃度異常. 研修医通信:19-24, 中外製薬, 2021
 
6) Martindale AM, et al:Understanding the implementation of 'sick day guidance' to prevent acute kidney injury across a primary care setting in England:a qualitative evaluation. BMJ Open, 7:e017241, 2017(PMID:29122792)
 
7) Richmond Hospital Preventable Adverse Drug Event (pADE) study:Resources:Sick Day Medication Management (for physicians and pharmacists) https://www.vchri.ca/richmond/pADE
 
8) 日本麻酔科学会:安全な中心静脈カテーテル挿入・管理のためのプラクティカルガイド2017 https://anesth.or.jp/files/pdf/JSA_CV_practical_guide_2017.pdf
 
9) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1-138, 2012 https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-GuidelineEnglish.pdf
 
10) Granata A, et al:Quiz page. Right internal thoracic cannulation by CVC for hemodialysis therapy. Am J Kidney Dis, 51:A42-A44, 2008(PMID:18436077)
 
11) 日本医療安全調査機構(医療事故調査・支援センター):中心静脈カテーテル挿入・抜去に係る死亡事例の分析 第2報(改訂版)(2023年3月) https://www.medsafe.or.jp/modules/advocacy/index.php?content_id=137
 
P.121 掲載の参考文献
1) 志水英明:心にのこる症例 身近にある薬剤の電解質異常-低カリウム血症が高ナトリウム血症にかわる! medicina, 54:1714-1718, 2017
 
2) 「輸液グリーンノート」(志水英明/編著), 中外医学社, 2021
 
3) 「研修医のための輸液・水電解質・酸塩基平衡」(藤田芳郎, 他/編), 中外医学社, 2015
 
4) 「より理解を深める!体液電解質異常と輸液 改訂3版」(深川雅史/監, 柴垣有吾/著), 中外医学社, 2007
 
5) Clase CM, et al:Potassium homeostasis and management of dyskalemia in kidney diseases:conclusions from a Kidney Disease:Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 97:42-61, 2020(PMID:31706619)
 
6) Kitabchi AE, et al:Management of hyperglycemic crises in patients with diabetes. Diabetes Care, 24:131-153, 2001(PMID:11194218)
 
P.134 掲載の参考文献
1) Smith JD, et al:Misclassification of Calcium Status Based on Albumin-Adjusted Calcium:Studies in a Tertiary Hospital Setting. Clin Chem, 64:1713-1722, 2018(PMID:30352866)
 
2) Smogorzewski MJ, et al:Disorders of Calcium, Magnesium, and Phosphate Balance. [Brenner and Rector's The Kidney 10th ed]((Alan SL Yu, et al/eds), Elsevier, 2015
 
3) Do C, et al:Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment:Core Curriculum 2022. Am J Kidney Dis, 80:536-551, 2022(PMID:35525634)
 
4) Felsenfeld AJ & Levine BS:Milk alkali syndrome and the dynamics of calcium homeostasis. Clin J Am Soc Nephrol, 1:641-654, 2006(PMID:17699269)
 
5) Tanvetyanon T & Stiff PJ:Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol, 17:897-907, 2006(PMID:16547070)
 
6) Felsenfeld AJ & Levine BS:Approach to treatment of hypophosphatemia. Am J Kidney Dis, 60:655-661, 2012(PMID:22863286)
 
7) Cairo MS & Bishop M:Tumour lysis syndrome:new therapeutic strategies and classification. Br J Haematol, 127:3-11, 2004(PMID:15384972)
 
8) Coiffier B, et al:Guidelines for the management of pediatric and adult tumor lysis syndrome:an evidence-based review. J Clin Oncol, 26:2767-2778, 2008(PMID:18509186)
 

第3章 コモンディジーズ

P.154 掲載の参考文献
1) 循環器学会:急性・慢性心不全診療ガイドライン(2017年改訂版), 2018 https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h.pdf
 
2) Nohria A, et al:Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol, 41:1797-1804, 2003(PMID:12767667)
 
3) 「エビデンスに基づくCKD診療ガイドライン2023」(日本腎臓学会/編), 東京医学社, 2023
 
4) McKee PA, et al:The natural history of congestive heart failure:the Framingham study. N Engl J Med, 285:1441-1446, 1971(PMID:5122894)
 
5) 「見える!できる!気管挿管」(青山和義/著), 羊土社, p114, 2019
 
6) Brower RG, et al:Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 342:1301-1308, 2000(PMID:10793162)
 
7) Konstam MA, et al:Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial. JAMA, 297:1319-1331, 2007(PMID:17384437)
 
8) De Backer D & Fagnoul D:Intensive care ultrasound:VI. Fluid responsiveness and shock assessment. Ann Am Thorac Soc, 11:129-136, 2014(PMID:24460447)
 
P.173 掲載の参考文献
1) Chapter 27 Hypokalemia. [Clinical Physiology of Acid-Base and Electrolyte Disorders 5th ed](Rose BD & Post TW/eds), McGraw-Hill, 2001
 
2) Palmer BF:A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis, 56:1184-1190, 2010(PMID:20828906)
 
3) Wu KL, et al:Identification of the Causes for Chronic Hypokalemia:Importance of Urinary Sodium and Chloride Excretion. Am J Med, 130:846-855, 2017(PMID:28213045)
 
4) 中山裕史, 冨田公夫:輸液-病態別メニューの考え方. 日腎会誌, 50:100-109, 2008(PMID:18421965)
 
5) Do C, et al:Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment:Core Curriculum 2022. Am J Kidney Dis, 80:536-551, 2022(PMID:35525634)
 
6) Yi JH, et al:Metabolic alkalosis from unsuspected ingestion:use of urine pH and anion gap. Am J Kidney Dis, 59:577-581, 2012(PMID:22265393)
 
7) Marston N, et al:Alkalotics anonymous:severe metabolic alkalosis. Am J Med, 127:25-27, 2014(PMID:24268303)
 
8) Gennari FJ & Weise WJ:Acid-base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol, 3:1861-1868, 2008(PMID:18922984)
 
9) Sterns RH, et al:Treating profound hyponatremia:a strategy for controlled correction. Am J Kidney Dis, 56:774-779, 2010(PMID:20709440)
 
10) Ryuge A, et al:Hyponatremic Chloride-depletion Metabolic Alkalosis Successfully Treated with High Cation-gap Amino Acid. Intern Med, 55:1765-1767, 2016(PMID:27374680)
 
11) Asmar A, et al:A physiologic-based approach to the treatment of a patient with hypokalemia. Am J Kidney Dis, 60:492-497, 2012(PMID:22901631)
 
12) Chapter 9 Disorders of Potassium Metabolism. [Comprehensive Clinical Nephrology 6th ed](Johnson R et al/eds), Elsevier, 2018
 
13) Mehanna HM, et al:Refeeding syndrome:what it is, and how to prevent and treat it. BMJ, 336:1495-1498, 2008(PMID:18583681)
 
14) Bioletto F, et al:Impact of Refeeding Syndrome on Short- and Medium-Term All-Cause Mortality:A Systematic Review and Meta-Analysis. Am J Med, 134:1009-1018.e1, 2021(PMID:33864767)
 
15) Viera AJ & Wouk N:Potassium Disorders:Hypokalemia and Hyperkalemia. Am Fam Physician, 92:487-495, 2015(PMID:26371733)
 
16) Chapter 16 Disorders of Acid-base Balance. [Brenner and Rector's The Kidney 11th ed](Alan SL Yu, et al/eds), Elsevier, 2019
 
17) Seifter JL & Chang HY:Disorders of Acid-Base Balance:New Perspectives. Kidney Dis (Basel), 2:170-186, 2017(PMID:28232934)
 
18) Mount DB:Evaluation of the adult patient with hypokalemia, UpToDate, 2021 https://www.uptodate.com/contents/evaluation-of-the-adult-patient-with-hypokalemia
 
19) Gennari FJ:Hypokalemia. N Engl J Med, 339:451-458, 1998(PMID:9700180)
 
20) Cohn JN, et al:New guidelines for potassium replacement in clinical practice:a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med, 160:2429-2436, 2000(PMID:10979053)
 
21) Sterns RH, et al:Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore), 60:339-354, 1981(PMID:6268928)
 
22) Erratum Regarding "Physiology and Pathophysiology of Potassium Homeostasis:Core Curriculum 2019" (Am J Kidney Dis. 2019;74[5]:682-695). Am J Kidney Dis, 80:690, 2022(PMID:36273834)
 
P.192 掲載の参考文献
1) 江木盛時, 他:日本版 敗血症診療ガイドライン 2020. 日集中医誌, 28(Suppl):S1-S411, 2021
 
2) Doherty M & Buggy DJ:Intraoperative fluids:how much is too much? Br J Anaesth, 109:69-79, 2012(PMID:22661747)
 
3) Manning MW, et al:Perioperative fluid and hemodynamic management within an enhanced recovery pathway. J Surg Oncol, 116:592-600, 2017(PMID:28940567)
 
4) Deng QW, et al:Is goal-directed fluid therapy based on dynamic variables alone sufficient to improve clinical outcomes among patients undergoing surgery? A meta-analysis. Crit Care, 22:298, 2018(PMID:30428928)
 
5) Cuesta M & Thompson C:The relevance of hyponatraemia to perioperative care of surgical patients. Surgeon, 13:163-169, 2015(PMID:25523069)
 
6) Marik PE & Lemson J:Fluid responsiveness:an evolution of our understanding. Br J Anaesth, 112:617-620, 2014(PMID:24535603)
 
P.202 掲載の参考文献
1) 日本移植学会:2021臓器移植ファクトブック. http://www.asas.or.jp/jst/pro/factbook/
 
2) Saidi RF, et al:Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys:realities and costs. Am J Transplant, 7:2769-2774, 2007(PMID:17927805)
 
3) 2015年版 日本透析医学会 慢性腎臓病患者における腎性貧血治療のガイドライン. 透析会誌, 49:89-158, 2016
 
4) Calixto Fernandes MH, et al:Perioperative fluid management in kidney transplantation:a black box. Crit Care, 22:14, 2018(PMID:29368625)
 
5) De Gasperi A, et al:Perioperative fluid management in kidney transplantation:is volume overload still mandatory for graft function? Transplant Proc, 38:807-809, 2006(PMID:16647477)
 
6) [Handbook of Kidney Transplantation 6th ed](Danovitch GM/ed), p244, LWW, 2017
 
7) Burdett E, et al:Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev, 12:CD004089, 2012(PMID:23235602)
 
8) O'Malley CMN, et al:A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg, 100:1518-1524, 2005(PMID:15845718)
 
9) Toyoda D, et al:The comparison between stroke volume variation and filling pressure as an estimate of right ventricular preload in patients undergoing renal transplantation. J Anesth, 29:40-46, 2015(PMID:24962946)
 
10) [Handbook of Kidney Transplantation 6th ed](Danovitch GM/ed), p285, LWW, 2017
 
P.220 掲載の参考文献
1) Poole K & Froggatt K:Loss of weight and loss of appetite in advanced cancer:a problem for the patient, the carer, or the health professional? Palliat Med, 16:499-506, 2002(PMID:12465697)
 
2) von Haehling S & Anker SD:Cachexia as a major underestimated and unmet medical need:facts and numbers. J Cachexia Sarcopenia Muscle, 1:1-5, 2010(PMID:21475699)
 
3) Roeland EJ, et al:Management of Cancer Cachexia:ASCO Guideline. J Clin Oncol, 38:2438-2453, 2020(PMID:32432946)
 
4) Orrevall Y:Nutritional support at the end of life. Nutrition, 31:615-616, 2015(PMID:25770331)
 
5) 「終末期がん患者の輸液療法に関するガイドライン 2013年版」(日本緩和医療学会緩和医療ガイドライン委員会/編), 金原出版, 2013
 
6) Loprinzi CL, et al:Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol, 11:152-154, 1993(PMID:8418227)
 
7) Moertel CG, et al:Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer, 33:1607-1609, 1974(PMID:4135151)
 
8) Bruera E, et al:Action of oral methylprednisolone in terminal cancer patients:a prospective randomized double-blind study. Cancer Treat Rep, 69:751-754, 1985(PMID:2410117)
 
9) Popiela T, et al:Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol, 25:1823-1829, 1989(PMID:2483687)
 
P.234 掲載の参考文献
1) 日本腎臓学会, 他/編:腎障害患者におけるヨード造影剤使用に関するガイドライン2018. 日腎会誌, 61:933-1081, 2019
 
2) McDonald RJ, et al:Intravenous contrast material-induced nephropathy:causal or coincident phenomenon? Radiology, 267:106-118, 2013(PMID:23360742)
 
3) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1-138, 2012 https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf
 
4) European Society of Urogenital Radiology:ESUR guidelines on contrast agents 10.0(2018) https://www.esur.org/esur-guidelines-on-contrast-agents/
 
5) Mehran R, et al:A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention:derivation and validation from an observational registry. Lancet, 398:1974-1983, 2021(PMID:34793743)
 
6) Pannu N, et al:Prophylaxis strategies for contrast-induced nephropathy. JAMA, 295:2765-2779, 2006(PMID:16788132)
 
7) Solomon R:Hydration to prevent acute kidney injury after angiography:the AMACING trial. Coron Artery Dis, 28:629-631, 2017(PMID:29095208)
 
8) Rihal CS, et al:Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 105:2259-2264, 2002(PMID:12010907)
 
9) Tao Y, et al:Proteinuria as an independent risk factor for contrast-induced acute kidney injury and mortality in patients with stroke undergoing cerebral angiography. J Neurointerv Surg, 9:445-448, 2017(PMID:27106594)
 
10) Rudnick MR, et al:Nephrotoxicity of ionic and nonionic contrast media in 1196 patients:a randomized trial. The Iohexol Cooperative Study. Kidney Int, 47:254-261, 1995(PMID:7731155)
 
11) Rim MY, et al:The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury:a propensity-matched study. Am J Kidney Dis, 60:576-582, 2012(PMID:22658321)
 
12) Rosenstock JL, et al:The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol, 40:749-755, 2008(PMID:18438718)
PubMed
13) Kushner FG, et al:2009 focused updates:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 54:2205-2241, 2009(PMID:19942100)
 
14) Brar SS, et al:Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury:the POSEIDON randomised controlled trial. Lancet, 383:1814-1823, 2014(PMID:24856027)
 
15) Nijssen EC, et al:Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING):a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet, 389:1312-1322, 2017(PMID:28233565)
 
16) Weisbord SD & Palevsky PM:Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol, 3:273-280, 2008(PMID:17989201)
 
17) Mueller C, et al:Prevention of contrast media-associated nephropathy:randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med, 162:329-336, 2002(PMID:11822926)
 
18) Weisbord SD, et al:Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med, 378:603-614, 2018(PMID:29130810)
 
19) American College of Radiology:ACR Manual on Contrast Media 2020 https://xray.ufl.edu/wordpress/files/2020/05/2020_ACR_Manual_Contrast_Media.pdf
 
20) Parfrey PS, et al:Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med, 320:143-149, 1989(PMID:2643041)
 
21) Ellis JH, et al:Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate. AJR Am J Roentgenol, 213:W188-W193, 2019(PMID:31268731)
 
22) McDonald RJ, et al:Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology, 273:714-725, 2014(PMID:25203000)
 
23) Hirano K, et al:Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease:an interrupted time-series study. Nephrol Dial Transplant, 38:1249-1259, 2023(PMID:36099912)
 
24) Giacoppo D, et al:Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes:Pooled Analysis From the HORIZONS-AMI and ACUITY Trials. Circ Cardiovasc Interv, 8:e002475, 2015(PMID:26198286)
 
25) Hamani A, et al:Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis? Nephrol Dial Transplant, 13:1051-1052, 1998(PMID:9568886)
 
26) Takebayashi S, et al:No need for immediate dialysis after administration of low-osmolarity contrast medium in patients undergoing hemodialysis. Am J Kidney Dis, 36:226, 2000(PMID:10873899)
 

書評

最近チェックした商品履歴

Loading...